A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

NCT00786058 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

CONKO-Studiengruppe

Collaborators